Protocol 4: nasal spray approach Goal: Needle-free administration with acceptable bioavailability trade-off Duration: 20 days active, then 4-6 months off Schedule: Days 1-20: 10-15 mg epitalon intranasally, divided into 2-3 daily doses Days 21-180: Off cycle Repeat 1-2 times per year Formulation: Reconstitute in saline with 3 percent DMSO for improved nasal absorption
Ozempic label provides placebo-controlled adverse reaction rates for common events (5%) dominated by GI symptoms (dose-related increases in nausea, vomiting, diarrhoea, constipation/abdominal pain)
A coffee enema involves brewing coffee, letting it cool, and then squirting it up your back passage through a tube inserted into your rectum
Albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, orforglipron and semaglutide used in the clinic are monoGLP-1RAs, tirzepatide acts not only on GLP1R, but also on glucose-dependent receptors of insulinotropic peptide (GIP), and retatrutide is a triple agonist of GLP-1, GIP and glucagon receptors
J.NemecE
Mixing an approved drug with an investigational compound is the standard safety position